) has received the approval for its VetScan Canine Ehrlichia
Antibody Test Kit from the Center for Veterinary Biologicals of the
U.S. Department of Agriculture (USDA). This test finds use in the
identification of ehrlichiosis in dogs, caused by tick-borne
rickettsial parasites called Ehrlichia.
Ehrlichiosis is a form of bacterial infection caused by the
Rickettsiae family of bacteria. This disease affects both humans
and animals and usually gets transmitted through the bite of a
Abaxis' VetScan Canine Ehrlichia Antibody Test Kit employs a
patent-protected method of detecting antibodies reactive to outer
membrane proteins of the Ehrlichia bacteria. It is the only test
endorsed for the detection of antibodies for all three dominant
species that affect dogs in the U.S., namely, E. canis., E.
chafeensis and E. ewingii.
Abaxis offers physicians the convenience of purchasing each test
individually based on the medical need and history of the patient,
as well as factors like the occurrence of a particular disease in
his geographic area.
Per management, the USDA approval will open roads for Abaxis'
customers to utilize these lateral flow rapid tests to detect the
presence of canine heartworm, Lyme and Ehrlichia. According to
reliable sources, this test kit has the potential to enhance the
efficiency and the economics of conducting such tests for similar
Given that tick-borne diseases are more often region-specific,
the VetScan Canine Ehrlichia Antibody Test Kit holds significant
potential when it comes to providing regionally appropriate
diagnostics that can deliver improved patient outcomes in a time
and cost-effective manner.
Currently, Abaxis carries a Zacks Rank #3 (Hold). Some
better-ranked medical product stocks that warrant a look are
Nxstage Medical, Inc.
OraSure Technologies, Inc.
ICU Medical, Inc.
). While Nxstage sports a Zacks Rank #1 (Strong Buy), OraSure and
ICU Medical hold a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report
ABAXIS INC (ABAX): Free Stock Analysis Report
ORASURE TECH (OSUR): Free Stock Analysis Report
NXSTAGE MEDICAL (NXTM): Free Stock Analysis
ICU MEDICAL INC (ICUI): Free Stock Analysis
To read this article on Zacks.com click here.